Nacalai USA entered into a distribution agreement with LifeSensors related to the latter’s Ubiquitin Proteasome Pathway (UPP) research tools and recombinant protein-expression technologies in Japan, Singapore, South Korea, and Taiwan.
San Diego-based Nacalai USA and its parent company Nacalai Tesque, a Japanese life science research reagent and chemical company headquartered in Kyoto, will facilitate distribution in these regions.
